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a b s t r a c t
Purpose: to study 75 familial adenomatous polyposis (FAP) patients treated in a single insti-
tution in Ribeirão Preto/SP, from January 1981 to December 2011. 
Methods: this is a retrospective study and the following data were collected: gender, age, 
main symptoms, familial history, coexisting malignancies, surgical treatment, surgical 
morbidity and mortality, factors related to life quality. 
Results: median age was 29 years. Male-to-female ratio was 1.2:1. Bleeding was the most 
common symptom (62.6%). Colorectal cancer incidence was 25.5% (n = 19). Extracolonic 
neoplasia incidence was 8%. Colectomy with ileorectal anastomosis (IRA) was performed 
in 72% of the patients. Eighteen patients (24%) were submitted to proctocolectomy with 
“J-pouch” ileoanal anastomosis. In three patients (4%) proctocolectomy with terminal il-
eostomy was performed. Early and late complication rate were similar (22.7% × 24%). Ileal 
pouch surgery exhibited tendency to a higher morbidity and mortality but no signifi cance 
could be found. Overall mortality rate was 7.46%. Malignant neoplasia was the main cause 
of mortality, accounting for 60% of deaths. 
Conclusion: FAP is a rare pathology in our country. Genetic counseling and proper screening 
programs are essential tools to early diagnosis and follow-up.  Surgery is the most effective 
treatment and the best option to prevent malignant neoplasia.
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Palavras-chave:
Polipose adenomatosa familiar
Câncer colorretal
Bolsa ileal
r e s u m o
Características clínicas e epidemiológicas da polipose adenomatosa 
familiar em Ribeirão Preto
Objetivo: analisar 75 pacientes com polipose adenomatosa familiar (PAF) tratados no Hos-
pital das clínicas da Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 
entre janeiro de 1981 a dezembro de 2011. 
Materiais e métodos: trata-se de estudo retrospectivo com coleta dos seguintes dados: sexo, 
idade, sintomas principais, história familiar, presença de malignidade, cirurgia realizada, 
morbidade e mortalidade cirúrgicas e fatores relacionados à qualidade de vida. 
Resultados: a idade média encontrada foi de 29 anos. A razão entre os sexos foi de 1,2:1 com 
predomínio no sexo masculino. Sangramento intestinal foi o sintoma mais comum (62,7%). 
A incidência de câncer colorretal foi de 25,3% (n = 19). Neoplasias extracolônicas foram 
diagnosticadas em 8% dos pacientes. Colectomia total com íleo-reto anastomose (IRA) foi 
realizada em 72% (n = 54) dos pacientes. Proctocolectomia com anastomose ileoanal e bolsa 
ileal em “J” foi realizada em 24% (n = 18) dos casos e em 4% (n=3) dos pacientes optou-se 
pela proctocolectomia com ileostomia terminal (PCI). As taxas de complicações precoces 
e tardias foram semelhantes (22,7% × 24%). A cirurgia de bolsa ileal apresentou tendência 
a maior morbimortalidade, porém sem relevância estatística. A taxa geral de mortalidade 
foi de 7,46%. Neoplasias malignas foram responsáveis por 60% dos óbitos e complicações 
cirúrgicas por 40%. 
Conclusões: a PAF é uma patologia de baixa incidência no nosso país. O aconselhamento 
genético e o rastreamento familiar são instrumentos essenciais para o diagnóstico precoce 
e seguimento adequado.  A cirurgia persiste como melhor opção para prevenção do câncer 
colorretal e tratamento da doença
Introduction
Familial adenomatous polyposis (FAP) is an autosomal domi-
nant genetic syndrome first described in 1721 by Menzelio.1 It 
is the result of a germline mutation in the adenomatous pol-
yposis coli (APC) gene located in chromosome 5q21 respon-
sible for cell growth and apoptosis regulation.2 In its classical 
phenotype, patients develop hundreds to a thousand adeno-
matous polyps between the second and third decades of life.3 
There is also a milder form of the disease called attenuated 
FAP (AFAP) with fewer polyps throughout the colon. Both ex-
hibit precancerous nature and, without proper treatment, de-
generation to colorectal carcinoma (CRC) is inexorable by the 
fifth to sixth decades of life. There are no studies regarding 
the incidence of FAP in our country but worldwide incidence 
is considered the same and estimated at one in every 5,000-
10,000 live births.4
Family history is of great importance for diagnosis because 
most patients are asymptomatic or present with nonspecific 
symptoms such as intestinal bleeding, abdominal pain or 
changes in bowel habit.5 FAP may also present with other 
complications such as desmoid tumors, adenocarcinoma of 
the small bowel, thyroid cancer, medulloblastomas and os-
teomas.6-8
Surveillance of patients leads to a reduction in CRC-re-
lated mortality.9,10 Individuals with a positive family history 
should begin annual colon evaluation (i.e. sigmoidoscopy or 
colonoscopy) by 10-12 years of age.11 Genetic tests are use-
ful to confirm an APC gene mutation. Once the mutation is 
discovered in an individual, genetic testing can help identify 
affected members of the same family. 
Surgery is the definitive treatment and options include proc-
tocolectomy with terminal ileostomy (PCI), colectomy with ileo-
rectal anastomosis (IRA) and proctocolectomy with ileal pouch 
anal anastomosis, also known as restorative proctocolectomy 
(RCP). Both the patient and the physician have to solve the dilem-
ma of neoplasia control and functional compromise to choose 
the right procedure. General agreement is that the surgeon must 
always consider the individual characteristics of each patient.
 The aim of this study is to describe the epidemiologic and 
clinical characteristics, as well as evaluate the outcome of a 
group of FAP patients treated in our institution.                                                                       
Metodology
This is a retrospective study of medical records of 75 patients 
with FAP. All patients were operated in Ribeirão Preto Medi-
cal School, University of São Paulo (USP), during the period 
of January 1981 to December 2011. The following data were 
collected: gender, age, main symptoms, upper gastrointesti-
nal endoscopy findings, family history, colonic and extra-co-
lonic malignant neoplasia, type of surgery, surgical morbidity 
and mortality, overall mortality. Factors related to life quality 
such as sexual dysfunction, bowel habit and fecal continence 
were also considered. Statistical analysis was performed with 
GraphPad 5.0 software program. Results of the two main sur-
gical options were compared using Fisher’s exact test. 
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Results
The present study included 75 patients. Average age was 29 
years (8 months-60 years) and men [41 (54.7%)] prevailed over 
women [34 (45.3%)]. The most common symptoms were intes-
tinal bleeding (62.7%), abdominal pain (40%), change in bowel 
habits (30%) and weight loss (14.7%). We discovered that sixty 
patients (80%) had other members of the family affected by 
FAP. Adenomatous polyps were found by upper gastrointes-
tinal endoscopy in 24 (32%) individuals, most of them in the 
stomach (75%).
CRC incidence was 25.3% (11 men and 8 women) and the 
average age of this group was 40.9 years old (22-59 years) 
[Fig. 1]. The diagnosis was made preoperatively in 73.7%, dur-
ing the surgery in 10.5% and during the follow-up in 15.8% of 
the cases. 
The incidence of extra-colonic neoplasia was 8% (4 desmoid 
tumors, 1 duodenal adenocarcinoma and 1 thyroid cancer).
Regarding the treatment, IRA was performed in 54 (72%) 
patients. Eighteen (24%) patients were submitted to RCP and 3 
(4%) undergone PCI.  The overall early and late post-operative 
complication rates were similar [22.7% (17 patients)] × [24% 
(18 patients), respectively]. We noticed a tendency of higher 
percentage rates of morbidity and mortality for RCP but no 
significance was found (Tables 1, 2 and 3).
The incidence of diarrhea and use of antidiarrheal agents 
after RCP was 33.3%. Reported incidence of fecal incontinence 
was 5%. The rate of diarrhea requiring pharmacologic treat-
ment after IRA was 11% and no fecal incontinence was report-
ed. Sexual dysfunction was noted only after IPAA in a rate of 
11%. Rectal cancer incidence after IRA was 3.7% (2 patients). 
The cancer incidence after IPAA was 5.5%  (one patient devel-
oped cuff adenocarcinoma).
Loss to follow-up rate was 10.7%. The maximum follow-
up time was 29 years. Overall mortality rate was 7.46% (5 pa-
tients). Advanced malignant neoplasia was the main cause of 
death [60% (3 patients)] and surgical complications (hypovole-
mic shock and necrohemorrhagic pancreatitis) accounted for 
the rest.
Discussion
The development of adenomas in FAP precedes symptoms 
and the disease remains silent for a long period of time. The 
Danish Polyposis Register analyzed the course of the disease 
and found a median age at diagnosis of FAP of 19 years.12 The 
present study found a higher mean age at diagnosis (29 years) 
that could be explained by the lack of compliance of screen-
ing programs, difficult access to healthcare and medical or 
patient’s negligence. 
The symptoms presented by the patients were intestinal 
bleeding (62.7%), abdominal pain (40%), change in bowel hab-
its (30%) and weight loss (14.7). We found that 42.7% of the 
patients were asymptomatic and FAP was diagnosed during 
screening of relatives.
Esophagogastroduodenoscopy helps the detection of 
gastric, duodenal and periampullary adenomas. Upper gas-
trointestinal cancer incidence in FAP is higher than general 
population but rare before the age of 30 years.13-15 General 
consensus recommends endoscopic surveillance starting 
from 25-30 years of age, at intervals of 1-5 years depend-
ing on the severity of the disease.16 The incidence of gastric 
and duodenal polyps in our study was 24% and 12% respec-
tively. Adenocarcinoma of duodenum was diagnosed in one 
(1.3%) patient.
Colorectal carcinoma is the main cause of death among 
patients with FAP. Most patients develop cancer by the age of 
Fig. 1 – Gender and age distribution of colonic 
adenocarcinomas.
Table 2 – Morbidity and mortality × surgical procedure.
Surgery Early 
complications 
(%)
Late 
complications 
(%)
Mortality  
(%)
IRA 22.2 20.4 3.7%
RCP 38.9 27.8 5.55%
PCI 0 0 0
IRA, colectomy with ileorectal anastomosis; RCP, restorative 
proctocolectomy; PCI, proctocolectomy with terminal ileostomy.
Table 3 – Surgical outcomes.
Surgical outcome IRA RCP P-value
Early morbidity 12 (22.2%) 7 (38.9%) 0.2181
Late morbidity 11 (20.4%) 6 (33.3%) 0.3379
Refractory diarrhea 6 (11.1%) 6 (33.3%) 0.0611
Follow-up cancer 2 (3.7%) 1 (5.55%) 1.00
Mortality 1 (1.85%) 1 (5.55%) 0.4401
IRA, colectomy with ileorectal anastomosis; RCP, restorative 
proctocolectomy, PCI, proctocolectomy with terminal ileostomy.
Table 1 – Early and late post-operative complications.
Complications
Early (%) Late (%)
Anastomotic leak 52.6 Obstruction 42.2
Abdominal abscess 21 Wound 
complications
15.8
Obstruction 15.8 Retrograde 
ejaculation
10.5
Pancreatitis 5.3 Fistulae 10.5
GI Bleeding 5.3 DVT 10.5
Wound complications 0 Stenosis 10.5
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39, thus making it important to evaluate the entire colon and 
to adhere the surveillance program.5,17 CRC was found in 19 
(25.3%) patients in the present study (Fig. 2). The diagnosis was 
made pre-operatively in 73.7% of the cases during colonoscopy.
Desmoid tumor is a benign neoplasia and the most impor-
tant extracolonic manifestation of FAP. It has an infiltrative 
growth pattern and a high recurrence rate after resection. 
Such aggressive behavior makes this neoplasia the second 
most common cause of death in FAP. Leal et al. found an in-
cidence of 13.2% in a series of 68 patients with no recurrence 
in a mean follow-up time of 63.1 months after treatment.18 
Another national registry reported an incidence of 11.9% in 
55 patients with 28.5% death rate.6 An English series of 88 
patients reported a cure rate of only 14% and deaths in 13% 
of the cases.19 The incidence of desmoid tumors in our study 
was 5.3% (4 patients). Half of the cases was located in the ab-
dominal wall and the other half inside the abdominal cavity. 
Curative resection was possible in three patients (75%) and 
no recurrences were noted. No deaths were attributed to this 
neoplasia (Fig. 3). 
Surgery is the most effective treatment option and contro-
versies regarding the best procedure still exist mainly because 
the choice depends on several factors such as age of the pa-
tient, sphincter function, mutation locus, number and site of 
the polyps, cancer association, patients’ commitment to long-
term follow-up, and experience of the surgeon.  There are no 
guidelines regarding the optimal timing of operation and most 
patients undergo surgery between 15-25 years of age.
Most patients in our study (54 [72%]) underwent IRA.  IRA is 
technically simpler than RCP with lower morbidity and mor-
tality rates. It also avoids the need for a permanent ileal stoma 
seen in PCI, with better quality of life.20,21 The main advantage 
of rectal preservation is better functional outcomes. Disad-
vantages are the need of periodic rectal surveillance for new 
polyps and the association to metachronous rectal cancer in 
some cases. It is usually recommended when there are very 
few polyps in the rectum (less than 20) and in patients with 
mild genotype.22,23 In the present study early and late compli-
cation rates were similar (22.2% × 20.4%). The main cause of 
early morbidity was anastomotic dehiscence (41.7%) and the 
most common late complication was intestinal obstruction 
(63.7%). Mortality rate related to the procedure was 1.85%.
Proctocolectomy with J-pouch ileoanal anastomosis is the 
gold standard treatment for FAP and was performed in 18 (24%) 
of the patients. This procedure is typically recommended when 
there are many polyps in the rectum or in patients with severe 
genotype  (i.e. mutations between codons 1250 and 1464).20,24,25 
Young women considering pregnancy should avoid or postpone 
RCP as fertility may be reduced as reported in some studies,26 
although a more recent one found no association with the type 
of operation.27 Early and late complications rates in our patients 
were 38.9% and 27.8%. Anastomotic dehiscence was the most 
common cause of morbidity (71.4%). Mortality rate was 5.5%.
We compared the outcomes of RCP x IRA and found no sta-
tistical difference in the rates of diarrhea requiring therapy, 
early and late complications, mortality and cancer incidence 
during follow-up.
Aziz et al. published a meta-analysis of studies that com-
pared RCP and IRA in 1002 patients.28 They found that bowel 
frequency, night defecation and use of incontinence pads were 
significantly less in the IRA group. They also noted that reoper-
ation within 30 days was more common after ileal pouch con-
struction. No significant differences between the techniques in 
terms of sexual dysfunction, dietary restriction, or postopera-
tive complications were noted. Rectal cancer was a diagnosis 
only in the ileorectal group. They concluded that both options 
have their merits.
Proctocolectomy with terminal ileostomy is the least per-
formed operation. Although very few complications are noted, 
the need of a permanent stoma may be considered unaccept-
able by young patients. It was performed in only 3% of the pa-
tients and no major complications were noted. There were no 
deaths in this subgroup.
Conclusion
FAP is an uncommon disease that affects young people cul-
minating with malignant neoplasia if untreated. Specialized 
centers are required to treat and follow this condition since 
it demands a multidisciplinary approach. Surgery is the de-
finitive treatment and data concerning FAP in our country is 
scarce, compromising a better understanding of the epidemi-
Fig. 3 – Desmoid tumor of the abdominal wall.
Fig. 2 – Invasive colorectal carcinoma in a patient with FAP.
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ology, clinical aspects and treatment outcomes. We believe 
that a national registry should ameliorate the problem and 
improve medical care.  
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